The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-1-((S)-3-(4-hydroxyphenyl)-2-((S)-5-oxopyrrolidine-2-carboxamido)propanoyl)pyrrolidine-2-carboxamide ID: ALA3953573
PubChem CID: 9952229
Max Phase: Preclinical
Molecular Formula: C19H24N4O5
Molecular Weight: 388.42
Molecule Type: Protein
Associated Items:
Names and Identifiers Canonical SMILES: NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCC(=O)N1
Standard InChI: InChI=1S/C19H24N4O5/c20-17(26)15-2-1-9-23(15)19(28)14(10-11-3-5-12(24)6-4-11)22-18(27)13-7-8-16(25)21-13/h3-6,13-15,24H,1-2,7-10H2,(H2,20,26)(H,21,25)(H,22,27)/t13-,14-,15-/m0/s1
Standard InChI Key: QFMGVKYIXZPFFF-KKUMJFAQSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
8.0541 -15.7000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.7686 -15.2875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4830 -15.7000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1976 -15.2875 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.4830 -16.5250 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.0541 -16.5250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3397 -16.9375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7686 -16.9375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.5864 -16.6071 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0344 -17.2202 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4469 -17.9347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2538 -17.7631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2138 -17.1340 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.7686 -14.4625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9513 -15.6180 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5034 -15.0049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0908 -14.2904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2839 -14.4621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1251 -16.4245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5135 -16.9783 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.9104 -16.6773 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.0541 -14.0500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0569 -13.2239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3433 -12.8114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6278 -13.2240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6305 -14.0533 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3447 -14.4620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9129 -12.8125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
3 5 2 0
1 6 1 0
7 6 1 6
6 8 2 0
7 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 7 1 0
10 13 2 0
2 14 1 1
4 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 4 1 0
15 19 1 1
19 20 1 0
19 21 2 0
14 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
25 28 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: ProteinTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 388.42Molecular Weight (Monoisotopic): 388.1747AlogP: -0.83#Rotatable Bonds: 6Polar Surface Area: 141.83Molecular Species: NEUTRALHBA: 5HBD: 4#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 5#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.50CX Basic pKa: ┄CX LogP: -1.14CX LogD: -1.15Aromatic Rings: 1Heavy Atoms: 28QED Weighted: 0.50Np Likeness Score: -0.18
References 1. (2010) TRH-like peptide derivatives as inhibitors of the TRH-degrading ectoenzyme,